Free Trial Information
BioCentury | Nov 26, 2019
Politics & Policy

Pioneering FDA commissioner Frank Young dies at 88

...NDA, for Probuphine, a long-acting, implantable buprenorphine product used to treat opioid dependence. Young joined TissueTech Inc....
Read More
BioCentury | Sep 2, 2013
Company News

TissueTech board of directors update

TissueTech Inc. , Doral , Fla. Business: Ophthalmic, Musculoskeletal Appointed: Carter McNabb, managing director at River Cities Capital Funds; and Matt Rice, principal at Ballast Point Ventures WIR Staff Musculoskeletal Ophthalmic...
Read More
BioCentury | Sep 2, 2013
Financial News

TissueTech completes venture financing

TissueTech Inc. , Doral , Fla. Business: Ophthalmic, Musculoskeletal Date completed: 8/16/13 Type: Venture financing Raised: $10 million Investors: Ballast Point Ventures; River Cities Capital Fund WIR Staff...
Read More
Items per page:
1 - 3 of 3
BioCentury | Nov 26, 2019
Politics & Policy

Pioneering FDA commissioner Frank Young dies at 88

...NDA, for Probuphine, a long-acting, implantable buprenorphine product used to treat opioid dependence. Young joined TissueTech Inc....
Read More
BioCentury | Sep 2, 2013
Company News

TissueTech board of directors update

TissueTech Inc. , Doral , Fla. Business: Ophthalmic, Musculoskeletal Appointed: Carter McNabb, managing director at River Cities Capital Funds; and Matt Rice, principal at Ballast Point Ventures WIR Staff Musculoskeletal Ophthalmic...
Read More
BioCentury | Sep 2, 2013
Financial News

TissueTech completes venture financing

TissueTech Inc. , Doral , Fla. Business: Ophthalmic, Musculoskeletal Date completed: 8/16/13 Type: Venture financing Raised: $10 million Investors: Ballast Point Ventures; River Cities Capital Fund WIR Staff...
Read More
Items per page:
1 - 3 of 3